Email UpdatesCOVID-19
This Topic Brief provides information on the impact of the COVID-19 pandemic on the behavioral health of the general public and healthcare workers, the impact of substance use disorders on COVID-19 outcomes, and other topics.
Report/Paper/Issue Brief
PDF documents of various lengths (though usually longer than one page), which have a practical application for clinical staff or others. Most fall into the category of grey literature, which includes government reports, white papers, and issue briefs. Generally this will not include peer-reviewed journal articles. Items often have a title or description that includes one of these terms.
Telehealth and Behavioral Health Integration
This Topic Brief aims to provide practical information and resources for using telehealth technologies to implement patient-centered integrated behavioral health care in primary and ambulatory care practices, including those related to substance use.
Substance Use and Substance Use Disorders by Race and Ethnicity, 2015-2019
This brief assesses whether and how rates of substance use and substance use disorder among adults differ by race and ethnicity using five years of data, 2015-2019, from the National Survey on Drug Use and Health.
Policies Should Promote Access to Buprenorphine for Opioid Use Disorder
This issue brief provides federal and state policymakers with ways they can support low-threshold buprenorphine prescribing through reimbursement policies, treatment guidelines, and regulations.
Spotlight on Legislation Limiting the Use of Prior Authorization for Substance Use Disorder Services and Medications
This report, produced in collaboration with the Partnership to End Addiction, analyzes standards of prior authorization requirements in both public and private insurance plans.
Practice-Based Guidelines: Buprenorphine in the Age of Fentanyl
These guidelines provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids.
Pain in the Nation 2023: The Epidemics of Alcohol, Drug, and Suicide Deaths
These recommendations from TFAH, primarily aimed at federal and state governments, aim to reduce alcohol, drug, and suicide deaths and to improve mental health and well-being for all Americans.
Overview of Opioid Treatment Program Regulations by State
This chartbook examines opioid treatment program regulations across all 50 states and the District of Columbia as of June 2021 in terms of access to care and patient experience.
Linking People with Opioid Use Disorder to Medication Treatment
This technical package presents strategies that can help state, local, and tribal leaders and healthcare professionals link persons living with OUD to evidence-based care.
Low Barrier Medication for Opioid Use Disorder at Community Health Centers and Primary Care Clinics: Recommendations for Implementation
This issue brief makes implementation recommendations for low-barrier medication for opioid use disorders.